How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

02 August 2024
HIV Outcomes hosted a multi-stakeholder roundtable discussion titled "Fostering Change in Policy and Clinical Practice in Europe" during AIDS 2024 in the Silver Zone. The session featured contributions from several Steering ...
More
26 March 2024
We are delighted to share with you HIV Outcomes Annual Review 2023!
More
12 December 2023
The HIV Outcomes initiative collaborated with MEP Frédérique Ries (Renew Europe Vice-President, Belgium), MEP Sara Cerdas (S&D, Portugal) and MEP Sirpa Pietikäinen (EPP, Finland) to organise ...
More
Filters
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.